Showing posts with label aspirin. Show all posts
Showing posts with label aspirin. Show all posts

Wednesday, March 1, 2017

Aspirin may help increase pregnancy chances in women with high inflammation, study finds

NIH: A daily low dose of aspirin may help a subgroup of women, those who have previously lost a pregnancy, to successfully conceive and carry a pregnancy to term, according to an analysis by researchers at the National Institutes of Health. The women who benefited from the aspirin treatment had high levels of C-reactive protein (CRP), a substance in the blood indicating system-wide inflammation, which aspirin is thought to counteract. The study appears in the Journal of Clinical Endocrinology and Metabolism.

Saturday, November 5, 2016

Aspirin and Cancer Risk Preventive effect strongest in colorectal and gastrointestinal tumors

Harvard: The regular use of aspirin significantly reduces the overall risk of cancer, according to an analysis led by Harvard Medical School researchers at Massachusetts General Hospital. Their review of data from two major, long-term epidemiologic studies also showed that the reduction primarily reflects a lower risk of colorectal cancer and other tumors of the gastrointestinal tract. The findings, published in JAMA Oncology, suggest that the use of aspirin may complement, but not replace, the preventive benefits of colonoscopy and other methods of cancer screening.

Friday, March 20, 2015

How our DNA may prevent bowel cancer

Melbourne: A new study published in the prestigious Journal of the American Medical Association  (JAMA) suggests the link between aspirin and colon cancer prevention may depend on a person’s individual genetics.

Monday, February 23, 2015

Appropriate use of aspirin for heart health evaluated

Baylor College. US: Many people have heard the advice to take an aspirin a day to help prevent heart attacks, however researchers at Baylor College of Medicine and the Michael E. DeBakey Veterans Affairs Medical Center reviewed a nationwide sample of patients receiving aspirin for primary cardiovascular disease prevention and found that 1 in 10 were receiving inappropriate aspirin therapy.